Dr. Martin Kriegel - Arthritis Research

Researchers on the Path to a Cure – Spotlight on Dr. Martin Kriegel

Trillions of bacteria live in or on your body. There are actually as many bacteria in your body as cells in your body. Fortunately, for most of us, most bacteria that live within us are helpful, not harmful. We call these bacteria commensal bacteria. Dr. Martin Kriegel and his team have been studying these bacteria, and more specifically, a protein that humans and bacteria produce, called Ro60, that plays a role in the development of lupus.

Continue reading Researchers on the Path to a Cure – Spotlight on Dr. Martin Kriegel

arthritis-foundation-statement-fy2018-budget

Arthritis Foundation Statement on the Official FY 2018 President’s Budget Request

Today, the president released the administration’s official budget request for fiscal year (FY) 2018, which would make deep cuts to health programs across health agencies and would have severe implications for Medicaid and other programs that deliver vital health care services to people with arthritis. While the Arthritis Foundation agrees that health care reform is necessary and our country needs to make important spending decisions, it should not be at the expense of people with arthritis, which now affects one in four Americans and the prevalence is growing.

Continue reading Arthritis Foundation Statement on the Official FY 2018 President’s Budget Request

Arthritis Biosimilar

FDA Approves Second Remicade biosimilar

The U.S. Food and Drug Administration (FDA) has approved Renflexis (infliximab-abda), a biosimilar to Remicade (infliximab), making it the fourth biosimilar approved to treat inflammatory types of arthritis.

Renflexis is the second approved biosimilar to Remicade. The first one, Inflectra (infliximab-dyyb), was approved in April 2016. This is the first time the FDA has approved two biosimilars for one original, “reference” medication.
Continue reading FDA Approves Second Remicade biosimilar

Arthritis Pain is Real

Share Your Story! Help Us Raise Awareness this Arthritis Awareness Month

More than 50 million Americans have arthritis – that’s one in four people. It’s currently the nation’s number one cause of disability.

But this month—with your help— we’re fighting back with the #FightFor50 campaign! To participate, we are asking that you share your story — tell us about your personal fight with arthritis, or tell us about a person you are fighting for, whether it’s parent, grandparent, sibling, partner or a friend.
Continue reading Share Your Story! Help Us Raise Awareness this Arthritis Awareness Month

Dr. Rae Yeung Arthritis Research

Researchers on the Path to a Cure – Spotlight on Dr. Rae Yeung

Dr. Rae Yeung believes in collaboration and building networks to solve problems. Her current 3-year Arthritis Foundation-funded project, “Precision Decisions to STOP JIA”, is an example of that. The goal is to develop a tool that will predict treatment response to specific drugs. Dr. Yeung’s study focuses on a group of high-risk children with polyarthritis, one of the most severe forms of childhood arthritis that affects many joints and is difficult to treat.
Continue reading Researchers on the Path to a Cure – Spotlight on Dr. Rae Yeung

Arthritis Research Dr. Bruce Cronstein

Researchers on the Path to a Cure – Spotlight on Dr. Bruce Cronstein

This story started with a dozen male research mice survivors from hurricane Sandy in 2012. The storm devastated Dr. Bruce Cronstein’s research lab, but born from the destruction was Dr. Cronstein’s 5-year Arthritis Foundation Investigator-funded project, “The Role of Adenosine Receptors in Osteoarthritis.”

He described the damage: “Our labs were closed for nearly a year and a half. We lost a lot of our animal facilities. However, once a lot of the debris was cleared, we were able to go in and found that some of our mice had survived.”
Continue reading Researchers on the Path to a Cure – Spotlight on Dr. Bruce Cronstein

American Health Care Act Arthritis Foundation Statement

The American Health Care Act: What You Need to Know

Things on the health care front are moving fast. Last week, the House voted to pass the American Health Care Act, a bill that changes several key features of the Affordable Care Act (also called “Obamacare”). The bill has moved on to the Senate where it could be voted on, as is, or amended and sent back to the House for further consideration.
Continue reading The American Health Care Act: What You Need to Know

AHCA Arthritis Foundation Action

House of Representatives Passes American Health Care Act – We Need Your Help to Amend AHCA When it Goes to the Senate

Earlier today, the House of Representatives passed the American Health Care Act (AHCA). We are concerned that the bill threatens access to affordable care for the chronically ill, including those who live with arthritis.

As the Senate considers the AHCA, we will work to amend the bill to make it truly patient-centered, but we need your help to send the message to legislators that the AHCA, as it sits today, is unacceptable for the 54 million Americans who live with arthritis, and the many more who have other chronic illnesses. Join our Advocate program today!
Continue reading House of Representatives Passes American Health Care Act – We Need Your Help to Amend AHCA When it Goes to the Senate

Living Your Yes with RA Events 2017

Coming this Fall – Living Your Yes With RA, A Personalized Goal-Setting Event

Living Your Yes with RA is a personalized goal-setting event brought to you by the Arthritis Foundation. This free forum gives you the opportunity to learn ways that can help you say Yes more than No, despite the challenges of living with rheumatoid arthritis (RA). You’ll get expert advice from a local rheumatologist plus guidance on setting goals that can help you live life to the fullest. Let us help you manage your RA, as well as communicate effectively with your own doctor.
Continue reading Coming this Fall – Living Your Yes With RA, A Personalized Goal-Setting Event